The Dutch health system has been undergoing transformational reform since the mid-2000s. The 2006 reform introduced managed competition as a driving mechanism in health care. Ten years of gradual implementation have changed and continue to change the health care system and the role of stakeholders. A second major reform in long term care (2015) aimed […]
Reforming Dutch long-term care Read More »
The European Medicines Agency (EMA) has produced a guide on the information the Agency publishes on centrally and non-centrally authorised medicines for human use. Providing an overview of the range of documents produced by EMA during the life span of a medicine, the guide covers early development, through initial evaluation, adoption of positive or negative
Information on human medicines Read More »
The European Food Safety Authority (EFSA) has been reviewing scientific advice on nutrient intakes and has set the following values for vitamin B6: 0.3 mg for infants aged 7-11 months; 0.6 to 1.4 mg for children aged 1-14; 1.7 mg for men and boys aged 15-17, and 1.6 mg for women and girls aged 15-17;
Guidelines on vitamin B6 Read More »
The European Health Parliament is a platform of 55 young professionals from across Europe, which aims to deliver high-level policy-oriented recommendations to positively influence and change the future of healthcare in Europe. It has just published ‘Rethinking European Healthcare: recommendations by the next generation’. It covers proposals on: antimicrobial resistance climate change and health digital
Rethinking European health care Read More »
The expert group on health systems performance assessment (HSPA) provides participating countries with a forum to exchange experiences on the use of HSPA at a national level. It also supports national policy-makers by identifying tools and methodologies for developing HSPA. It is composed of European countries’ health authorities as well as international organisations and has
Assessing quality of care Read More »
All populations will be affected by climate change, but some are more vulnerable than others. In Europe it will be people living on small islands, in coastal regions and on rivers who will be particularly vulnerable. WHO have produced a fact sheet on climate change and health which provides key facts, outlines patterns of infection,
Climate change and health Read More »
The WHO Regional Office for Europe has prepared a physical activity strategy to support the voluntary global targets set out in the WHO global action plan for the prevention and control of noncommunicable diseases 2013–2020. The strategy focuses on physical activity as a leading factor in health and well-being in the European Region, with particular
Physical activity strategy 2016–2025 Read More »
The nutritional well-being of pregnant women affects not only their fetuses’ development but also children’s long-term risk of developing non-communicable diseases (NCDs) or obesity, according to a new report from WHO/Europe “Good maternal nutrition. The best start in life”. While the importance of good nutrition in the early development of children has been recognized for
Maternal nutrition linked to children’s risk of NCDs and obesity Read More »
Global consumption of antibiotics in human medicine rose by nearly 40{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} in the decade from 2000 and in 2007 25,000 people a year in the EU were dying from an infection due to antibiotic-resistant bacteria. Infections due to these multi-drug resistant bacteria are estimated to cost the EU at least €1.5 billion a year in
Need for greater EU action on antimicrobial resistance Read More »
Endocrine disruptors are chemicals which impact on the hormone system of animals and humans. They have three cumulative characteristics: a hormonal function, an adverse effect, and a causality between the two. There has been increasing interest in endocrine disruptors and the European Commission has produced a factsheet that answers some of the most common questions
Endocrine disruptors Read More »
